Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of saline tract sealing after CT-Guided lung biopsy: a systematic review and meta-analysis.

Clinical radiology·2026
Same author

Chitosan-Calcium-Simvastatin Scaffold as an Inductive Cell-Free Platform.

Journal of dental research·2021
Same author

Canola meal as a novel substrate for β-glucosidase production by Trichoderma viride: application of the crude extract to biomass saccharification.

Bioprocess and biosystems engineering·2015
Same author

Influence of lairage environmental conditions and resting time on meat quality in pigs.

Meat science·2011
Same author

Fibrin deposits and organ failure in newborn foals with severe septicemia.

Journal of veterinary internal medicine·2008
Same author

900-nm Nd:Ti:LiNbO(3) waveguide laser.

Optics letters·2008

Related Experiment Video

Updated: Jul 9, 2026

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.

L T Santamaria Saber1, M Y Ikeda, J M Almeida

  • 1Renal Transplant Unit, Hospital das Clinicas, University of São Paulo-Ribeirão Preto, São Paulo, Brazil.

Transplantation Proceedings
|December 20, 2007
PubMed
Summary

Sirolimus (SRL) improves kidney transplant function after conversion, particularly for chronic allograft nephropathy (CAN). However, reducing immunosuppression is crucial to mitigate side effects like infections and myelotoxicity.

More Related Videos

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
10:31

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model

Published on: August 13, 2017

Related Experiment Videos

Last Updated: Jul 9, 2026

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
10:31

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model

Published on: August 13, 2017

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Pharmacology

Background:

  • Sirolimus (SRL) is an emerging option for kidney transplant recipients, especially those with chronic allograft nephropathy (CAN).
  • Calcineurin inhibitor (CNI) nephrotoxicity and CAN are primary reasons for switching immunosuppressive therapy.

Purpose of the Study:

  • To evaluate the safety and efficacy of sirolimus (SRL) conversion in kidney transplant recipients.
  • To assess the impact of SRL on renal function and identify associated adverse events.

Main Methods:

  • A cohort of 103 kidney recipients underwent conversion to SRL-based immunosuppression.
  • Renal function was monitored by proteinuria and inverse serum creatinine pre- and post-conversion.
  • Adverse events and reasons for SRL discontinuation were recorded.

Main Results:

  • Significant improvement in renal function was observed at 1 month post-conversion, with stabilization thereafter.
  • Common side effects included anemia and leukopenia with SRL/mycophenolate mofetil (MMF).
  • Infections and graft loss due to CAN were significant concerns.

Conclusions:

  • Sirolimus (SRL) offers a viable therapeutic option for kidney transplant recipients, particularly those with chronic allograft nephropathy (CAN).
  • Reducing the intensity of associated immunosuppression is recommended to minimize adverse events, especially infections.
  • Careful monitoring for side effects is essential during SRL therapy.